Skip to content

Drug interactions

Lorlatinib + Losartan

Severity: Minor

Lorlatinib and Losartan: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lorlatinib is a moderate CYP3A inducer and may lower exposure to losartan, which is partly converted to its active metabolite by CYP3A4 and CYP2C9. The clinical effect is likely a modest reduction in blood pressure control.

What this interaction means in plain words

Lorlatinib and Losartan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lorlatinib belongs to Oncology; Losartan belongs to Cardiovascular.

Evidence level: Low

Why it happens

Induction of CYP3A4 by lorlatinib may increase losartan metabolic clearance.

What to do

Monitor blood pressure when lorlatinib is started or stopped and titrate losartan dose if control changes.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lorlatinib and Losartan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lorlatinib with Losartan?

MediHelp rates the interaction as minor. Lorlatinib and Losartan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lorlatinib is a moderate CYP3A inducer and may lower exposure to losartan, which is partly converted to its active metabolite by CYP3A4 and CYP2C9. The clinical effect is likely a modest reduction in blood pressure control.

How serious is the interaction between Lorlatinib and Losartan?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure when lorlatinib is started or stopped and titrate losartan dose if control changes.

What other medicines interact with Losartan?

MediHelp also lists interactions of Losartan with, for example, Aliskiren, Sparsentan, Amifostine. The full list is on the Losartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in